Atossa gets FDA rare pediatric disease status for McCune-Albright drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Atossa gets FDA rare pediatric disease status for McCune-Albright drug
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 1.90 +0.07 (3.83%)
Previous Close $1.83    52 Week High $3.64 
Open $1.82    52 Week Low $0.14 
Day High $1.96    P/E N/A 
Day Low $1.78    EPS $0.00 
Volume 534,889